Literature DB >> 31006703

Joint Indian Chest Society-National College of Chest Physicians (India) guidelines for spirometry.

Ashutosh Nath Aggarwal1, Ritesh Agarwal1, Sahajal Dhooria1, K T Prasad1, Inderpaul S Sehgal1, Valliappan Muthu1, Navneet Singh1, D Behera1, S K Jindal1, Virendra Singh1, Rajesh Chawla1, J K Samaria1, S N Gaur1, Anurag Agrawal1, S K Chhabra1, Vishal Chopra1, D J Christopher1, Raja Dhar1, Aloke G Ghoshal1, Randeep Guleria1, Ajay Handa1, Nirmal K Jain1, Ashok K Janmeja1, Surya Kant1, G C Khilnani1, Raj Kumar1, Ravindra Mehta1, Narayan Mishra1, Anant Mohan1, P R Mohapatra1, Dharmesh Patel1, Babu Ram1, S K Sharma1, Rupak Singla1, J C Suri1, Rajesh Swarnakar1, Deepak Talwar1, R Lakshmi Narasimhan1, Saurabh Maji1, Ankan Bandopadhyay1, Nita Basumatary1, Arindam Mukherjee1, Milind Baldi1, Nandkishore Baikunje1, Hariprasad Kalpakam1, Pratap Upadhya1, Rakesh Kodati1.   

Abstract

Although a simple and useful pulmonary function test, spirometry remains underutilized in India. The Indian Chest Society and National College of Chest Physicians (India) jointly supported an expert group to provide recommendations for spirometry in India. Based on a scientific grading of available published evidence, as well as other international recommendations, we propose a consensus statement for planning, performing and interpreting spirometry in a systematic manner across all levels of healthcare in India. We stress the use of standard equipment, and the need for quality control, to optimize testing. Important technical requirements for patient selection, and proper conduct of the vital capacity maneuver, are outlined. A brief algorithm to interpret and report spirometric data using minimal and most important variables is presented. The use of statistically valid lower limits of normality during interpretation is emphasized, and a listing of Indian reference equations is provided for this purpose. Other important issues such as peak expiratory flow, bronchodilator reversibility testing, and technician training are also discussed. We hope that this document will improve use of spirometry in a standardized fashion across diverse settings in India.

Entities:  

Keywords:  Guidelines; India; spirometry

Year:  2019        PMID: 31006703      PMCID: PMC6489506          DOI: 10.4103/lungindia.lungindia_300_18

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


  5 in total

1.  Quality of spirometry testing in a community setting: A study among elderly persons in a rural area of Haryana.

Authors:  Ravneet Kaur; Alok Kumar; Vijay Hadda; M Kalaivani; Baridalyne Nongkynrih; Shashi Kant; Sanjeev K Gupta; Dwarakanathan Vignesh
Journal:  J Family Med Prim Care       Date:  2019-11-15

2.  A mixed-methods community-based participatory research to explore stakeholder's perspectives and to quantify the effect of crop residue burning on air and human health in Central India: study protocol.

Authors:  Tanwi Trushna; Vishal Diwan; Subroto Shambhu Nandi; Satish Bhagwatrao Aher; Rajnarayan R Tiwari; Yogesh Damodar Sabde
Journal:  BMC Public Health       Date:  2020-11-30       Impact factor: 3.295

3.  Lung Function Impairment In Patients Treated For Pulmonary Tuberculosis and Associated Factors in Puducherry, South India.

Authors:  Mounika Pydipalli; Palanivel Chinnakali; Manju Rajaram; Shanthosh Priyan Sundaram; Gautam Roy
Journal:  Indian J Community Med       Date:  2022-03-16

4.  Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma.

Authors:  Ritesh Agarwal; Puneet Saxena; Valliappan Muthu; Inderpaul Singh Sehgal; Sahajal Dhooria; Kuruswamy Thurai Prasad; Ashutosh Nath Aggarwal; Arunaloke Chakrabarti
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

5.  Environmental monitoring and health assessment in an industrial town in central India: A cross-sectional study protocol.

Authors:  Tanwi Trushna; Vikas Dhiman; Satish Bhagwatrao Aher; Dharma Raj; Rajesh Ahirwar; Swasti Shubham; Subroto Shambhu Nandi; Rajnarayan R Tiwari
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.